SCHEMBL2808191

SCHEMBL2808191

Cc1ccc(-c2ccc(C(=O)O)cc2)cc1Cn1c(C(=O)OC(C)(C)C)c(-c2ccc(C(C)(C)C)cc2)c2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 2/20 0.45
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42
ALDH1A1 P00352 1/20 0.42
KMT2A Q03164 1/20 0.42
PIN1 Q13526 2/20 0.40
FOLH1 Q04609 1/20 0.39
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
PTGES O14684 1/20 0.38
ALOX5 P09917 1/20 0.38
EDNRB P24530 2/20 0.37
EDNRA P25101 2/20 0.37
PPARG P37231 3/20 0.37
MAPK8 P45983 2/20 0.37
PTGER4 P35408 1/20 0.37
MAPT P10636 1/20 0.37
RORC P51449 1/20 0.36
NR1H4 Q96RI1 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2808598 0.93 SERPINE1 (0.44) SERPINE1MEN1USP2ALDH1A1KMT2A
SCHEMBL2810186 0.91 SERPINE1 (0.54) SERPINE1MEN1USP2ALDH1A1KMT2A
SCHEMBL2805537 0.90 SERPINE1 (0.46) SERPINE1MEN1USP2ALDH1A1KMT2A
SCHEMBL13168630 0.88 PIN1 (0.44) SERPINE1MEN1USP2ALDH1A1KMT2A
SCHEMBL2810307 0.87 SERPINE1 (0.41) SERPINE1MEN1USP2ALDH1A1KMT2A
SCHEMBL2806589 0.84 SERPINE1 (0.43) SERPINE1MEN1USP2ALDH1A1KMT2A
SCHEMBL2807928 0.84 KDM4E (0.44) SERPINE1MEN1USP2ALDH1A1KMT2A
SCHEMBL2807914 0.84 SERPINE1 (0.54) SERPINE1MEN1USP2ALDH1A1KMT2A
SCHEMBL2809001 0.83 SERPINE1 (0.50) SERPINE1MEN1USP2ALDH1A1KMT2A
SCHEMBL2805766 0.83 SERPINE1 (0.45) SERPINE1MEN1USP2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators SMITHKLINE BEECHAM CORPORATION (US) 2010-09-23 US disclosed
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators SMITHKLINE BEECHAM CORPORATION (US) 2010-09-23 US disclosed
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators SMITHKLINE BEECHAM CORPORATION (US) 2010-09-23 US disclosed
EP-2081894-A1 1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS PPAR MODULATORS SmithKline Beecham Corporation (US) 2009-07-29 EP disclosed
WO-2008028118-A1 1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS PPAR MODULATORS SMITHKLINE BEECHAM CORPORAITON (US) 2008-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators PPARD, PPARA, PPARG SERPINE1 4215/4885MEN1 4809/4885USP2 2908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.